Abstract
Veno-occlusive disease (VOD) of the liver, also termed as sinusoidal obstruction syndrome, constitutes a well-known complication of high-dose cytoreductive chemotherapy prior to allogeneic or autologous bone marrow transplantation and is associated with the intensity of treatment [1]. On the contrary, there is only one report of VOD during induction therapy for acute lymphoblastic leukemia in a patient with Marfan syndrome, who was successfully treated with defibrotide [2]. In this article, we present the first fatal case of VOD during induction therapy for acute lymphoblastic leukemia.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
Female
-
Fibrinolytic Agents / administration & dosage
-
Hepatic Veno-Occlusive Disease / chemically induced*
-
Hepatic Veno-Occlusive Disease / pathology
-
Humans
-
Liver / pathology
-
Marfan Syndrome / drug therapy
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Middle Aged
-
Polydeoxyribonucleotides / administration & dosage
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Prednisolone / administration & dosage
-
Prednisolone / adverse effects
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Fibrinolytic Agents
-
Polydeoxyribonucleotides
-
defibrotide
-
Vincristine
-
Prednisolone
-
Asparaginase
-
Methotrexate
-
Daunorubicin